Antibody-based Theranostics

Antibody-Based Theranostics is a targeted molecular strategy within theranostic oncology that integrates monoclonal antibodies for both diagnostic imaging and therapeutic intervention, leveraging their high specificity toward tumor-associated antigens to enable precise cancer detection, monitoring, and treatment delivery.

60

Publications

2.8K

Citations

537

Authors

209

Institutions

Publications per year

2017–2026

43

Authors

537

  1. WC
    Weibo Cai

    University of Wisconsin–Madison, United States

    5 publications · 218 citations

    5

    h-index

  2. DJ
    Dawei Jiang

    University of Wisconsin–Madison, United States

    5 publications · 230 citations

    5

    h-index

  3. EB
    Emily B. Ehlerding

    University of Wisconsin–Madison, United States

    4 publications · 164 citations

    4

    h-index

  4. ND
    Nick Devoogdt

    Vrije Universiteit Brussel, Belgium

    4 publications · 351 citations

    4

    h-index

  5. JW
    Jonathan W. Engle

    University of Wisconsin–Madison, United States

    4 publications · 164 citations

    4

    h-index

1–5 of 537

Venues

  1. Journal of Nuclear Medicine

    7 publications · 243 citations

    7

    h-index

  2. Molecular Pharmaceutics

    5 publications · 183 citations

    5

    h-index

  3. Theranostics

    4 publications · 293 citations

    4

    h-index

  4. Nuclear Medicine and Biology

    NMB · 3 publications · 95 citations

    3

    h-index

  5. Advanced Science

    2 publications · 111 citations

    2

    h-index

1–5